Loading clinical trials...
Loading clinical trials...
The purpose of this study is to examine if infants are more likely to suffer from respiratory complications during their first year of life due to being born premature.
The overall objective of this study is to determine if infant respiratory morbidities after preterm birth are highly variable due to differential impairment of airway, parenchymal and vascular development that can be characterized as distinct physiologic phenotypes. If the nature and severity of these specific impairments of lung function are strongly associated with increased respiratory morbidities during infancy and that proteomic biomarkers can enhance the physiologic characterization of phenotype and prediction of late respiratory outcomes.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Jeff Bjerregaard
Indianapolis, Indiana, United States
Start Date
January 1, 2019
Primary Completion Date
June 25, 2024
Completion Date
December 1, 2026
Last Updated
February 19, 2026
249
ACTUAL participants
Diffusion Capacity of the Lung for Carbon Monoxide (DLCO)
OTHER
Lead Sponsor
Indiana University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions